Newsroom
Sorted by: Latest
-
Atara Biotherapeutics Appoints James Huang and Nachi Subramanian to Board of Directors
THOUSAND OAKS, Calif.--(BUSINESS WIRE)--Atara Biotherapeutics, Inc. (Nasdaq: ATRA), a leader in T-cell immunotherapy, leveraging its novel allogeneic Epstein-Barr virus (EBV) T-cell platform to develop transformative therapies for patients with cancer and autoimmune diseases, announced the appointment of James Huang and Nachi Subramanian to its Board of Directors, effective following the completion the Company’s previously announced $16 million offering that was announced on May 15, 2025. The o...
-
Strategic Storage Trust VI, Inc. Reports First Quarter 2025 Results
LADERA RANCH, Calif.--(BUSINESS WIRE)--Strategic Storage Trust VI, Inc. (“SST VI”) announced operating results for the three months ended March 31, 2025. "This quarter marks an important milestone for our company as we report our first same-store results." commented H. Michael Schwartz, President and CEO of Strategic Storage Trust VI, Inc. "I'm pleased to share that these results exceeded our expectations and reflect the underlying strength and quality of our portfolio across both the United St...
-
Port Houston Regular Commission Meeting
HOUSTON--(BUSINESS WIRE)--The Port Commission of the Port of Houston Authority will hold its Regular Monthly Meeting on Tuesday, May 20, 2025, beginning at 9:15 a.m. in the boardroom of the Port Houston Executive Office Building, located at 111 East Loop North, Houston, TX 77029. It will be conducted as a hybrid meeting and open to the public to attend in person or accessed virtually via WebEx webinar. The agenda and instructions for accessing Port Houston public meetings are available at https...
-
Almonty Industries Reports First Quarter 2025 Financial Results
TORONTO--(BUSINESS WIRE)--Almonty Industries Inc. (“Almonty” or the “Company”) (TSX: AII / ASX: AII / OTCQX: ALMTF / Frankfurt: ALI), a leading global producer of tungsten concentrate, today announced its first quarter 2025 financial results. Financial Summary: Unless otherwise indicated, all figures are expressed in Canadian dollars. Three Months Ended March 31, CAD$ in millions 2025 2024 Revenue $7.91 $7.82 Income from Mining Operations $0.752 $0.606 Operating Expenses $9.5 $4.3 Loss before...
-
Rosen Law Firm Encourages SelectQuote, Inc. Investors to Inquire About Securities Class Action Investigation – SLQT
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of SelectQuote, Inc. (NYSE: SLQT) resulting from allegations that SelectQuote may have issued materially misleading business information to the investing public. So What: If you purchased SelectQuote securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangem...
-
DNUT CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Krispy Kreme, Inc.
LOS ANGELES--(BUSINESS WIRE)--DNUT CLASS ACTION NOTICE: The Law Offices of Frank R. Cruz Files Securities Fraud Lawsuit Against Krispy Kreme, Inc....
-
CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--CAPR Investors Have Opportunity to Join Capricor Therapeutics, Inc. Fraud Investigation with the Schall Law Firm...
-
Securities Fraud Investigation Into UroGen Pharma Ltd. (URGN) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
LOS ANGELES--(BUSINESS WIRE)--The Law Offices of Frank R. Cruz announces an investigation of UroGen Pharma Ltd. (“UroGen” or the “Company”) (NASDAQ: URGN) on behalf of investors concerning the Company’s possible violations of federal securities laws. IF YOU ARE AN INVESTOR WHO LOST MONEY ON UROGEN PHARMA LTD. (URGN), CLICK HERE TO INQUIRE ABOUT POTENTIALLY PURSUING A CLAIM TO RECOVER YOUR LOSS. What Is The Investigation About? On May 16, 2025, the U.S. Food and Drug Administration (“FDA”) publi...
-
Rosen Law Firm Encourages GoHealth, Inc. Investors to Inquire About Securities Class Action Investigation – GOCO
NEW YORK--(BUSINESS WIRE)--Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of GoHealth, Inc. (NASDAQ: GOCO) resulting from allegations that GoHealth may have issued materially misleading business information to the investing public. So What: If you purchased GoHealth securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement. Th...
-
DNUT Investors Have Opportunity to Join Krispy Kreme, Inc. Fraud Investigation with the Schall Law Firm
LOS ANGELES--(BUSINESS WIRE)--DNUT Investors Have Opportunity to Join Krispy Kreme, Inc. Fraud Investigation with the Schall Law Firm...